Annaleigh Harper, PA
Medical · Little Rock, ARNPI 1629442132
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 419 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 419 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Lilly USA, LLC$1K
- AbbVie$846
- UCB, Inc.$784
- Sun Pharmaceutical Industries Inc.$749
- Johnson & Johnson$698
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,68092%
- Education$5708%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 79 | $1,199 |
| Lilly USA, LLC | 61 | $1,006 |
| AbbVie | 55 | $846 |
| UCB, Inc. | 45 | $784 |
| Sun Pharmaceutical Industries Inc. | 27 | $749 |
| Johnson & Johnson | 51 | $698 |
| LEO Pharma Inc. | 24 | $492 |
| E.r. Squibb & Sons, L.L.C. | 16 | $250 |
| Sanofi | 12 | $245 |
| Regeneron Healthcare Solutions, Inc. | 6 | $213 |
| Pfizer | 12 | $208 |
| Incyte Corporation | 9 | $197 |
| Dermavant Sciences, Inc. | 6 | $89 |
| Galderma Laboratories, L.p. | 5 | $82 |
| Amgen | 4 | $70 |
| Kyowa Kirin, Inc. | 2 | $49 |
| Organon | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
| Journey Medical Corporation | 1 | $13 |
| Biofrontera Inc. | 1 | $9 |
How this compares
$7,250 in reported general payments places this provider in the 90th percentile of 133 medical providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 64 | $3,725 |
| Ketoconazole | 136 | $2,530 |
| Doxycycline Hyclate | 75 | $1,760 |
| Imiquimod | 50 | $1,137 |
| Metronidazole | 23 | $1,091 |
| Clindamycin Phosphate | 28 | $682 |
| Betamethasone Dipropionate | 15 | $610 |
| Triamcinolone Acetonide | 80 | $586 |
| Nystatin | 20 | $263 |
| Spironolactone | 13 | $241 |
| Terbinafine Hcl | 13 | $121 |
| Hydrocortisone | 20 | $114 |
| Mupirocin | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other medical in Little Rock
- Douglas ClarkLittle Rock$14K
- Alexandra SanromaLittle Rock$11K
- Katherine McCradyLittle Rock$9K
- Bailey PollockLittle Rock$9K
- Hannah BreauLittle Rock$9K
- Rebecca DennistonLittle Rock$7K
- Patrick StickleLittle Rock$5K
- Arthur HallLittle Rock$4K
- Maggie BrownLittle Rock$1K
- Caylin MeisterLittle Rock$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.